Mereo BioPharma Group plc Holding(s) in Company (6671C)
11 Fevereiro 2020 - 12:00PM
UK Regulatory
TIDMMPH
RNS Number : 6671C
Mereo BioPharma Group plc
11 February 2020
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible)(i)
1a. Identity of the issuer or the Mereo Biopharma Group PLC
underlying issuer of existing shares
to which voting rights are attached(ii)
:
----------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights X
----
Other (please specify)(iii) :
----
3. Details of person subject to the notification obligation(iv)
Name Link Fund Solutions Ltd
City and country of registered office 6(th) Floor, 65 Gresham Street, London
(if applicable) EC2V 7NQ, United Kingdom
4. Full name of shareholder(s) (if different from 3.)(v)
Name
----------------------------------------------
City and country of registered office
(if applicable)
----------------------------------------------
5. Date on which the threshold was 10/02/2020
crossed or reached(vi) :
----------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 11/02/2020
----------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer(vii)
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ ---------------------- --------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 17.06% 17.06% 112,255,142
------------------ ---------------------- --------------- --------------------
Position of
previous notification
(if
applicable) 19.55% 19.55%
------------------ ---------------------- --------------- --------------------
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached(viii)
A: Voting rights attached to shares
Class/type of Number of voting rights(ix) % of voting rights
shares
ISIN code (if
possible)
--------------------------------------------- -----------------------------------------------
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
--------------------- ---------------------- ----------------------- ----------------------
GB00BZ4G2K23 19,153,667 17.06%
--------------------- ---------------------- ----------------------- ----------------------
SUBTOTAL 8. A
--------------------------------------------- -----------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive
2004/109/EC (DTR5.3.1.1 (a))
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion Period(xi) rights that may rights
be acquired if
the instrument
is
exercised/converted.
----------- ----------------------- ---------------------- ------------
SUBTOTAL 8. B 1
----------------------- ---------------------- ------------
B 2: Financial Instruments with similar economic effect according
to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial Expiration Exercise/ Physical or Number of % of voting
instrument date(x) Conversion cash voting rights rights
Period (xi) settlement(xii)
----------- ------------- ----------------- --------------- ------------
SUBTOTAL 8.B.2
----------------- --------------- ------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled X
by any natural person or legal entity and does not control
any other undertaking(s) holding directly or indirectly an
interest in the (underlying) issuer(xiii)
Full chain of controlled undertakings through which the voting
rights and/or the
financial instruments are effectively held starting with
the ultimate controlling natural person or legal entity(xiv)
(please add additional rows as necessary)
Name(xv) % of voting rights % of voting rights Total of both
if it equals or through financial if it equals or
is higher than instruments if is higher than
the notifiable it equals or is the notifiable
threshold higher than the threshold
notifiable threshold
------------------- ---------------------- -------------------
Link Fund Solutions
Ltd 17.06% 17.06%
------------------- ---------------------- -------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
-------------------------------------------
The number and % of voting rights
held
-------------------------------------------
The date until which the voting
rights will be held
-------------------------------------------
11. Additional information(xvi)
Place of completion 6(th) Floor, 65 Gresham Street, London EC2V 7NQ, United
Kingdom
Date of completion 11/02/2020
--------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
HOLTBMITMTIBBLM
(END) Dow Jones Newswires
February 11, 2020 10:00 ET (15:00 GMT)
Mereo Biopharma (LSE:MPH)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Mereo Biopharma (LSE:MPH)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
Notícias em tempo-real sobre Mereo Biopharma Group Plc da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Mereo Biopharma Group Plc